NDC 52544-348 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52544-348
- Package NDCs from labels
- 52544-348-30, 52544-348-01, 52544-348-05, 52544-348-10
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets USP Rx only | Watson Laboratories, Inc. | 2008-01-24 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52544-348-01 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 52544-348-05 | Triamterene and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 52544-348-10 | Triamterene and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 52544-348-30 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | c182b6a9-1a31-45ee-9cea-a557c99f5db7 | 2025-11-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ef8a7dee-3704-4c62-8981-f8adfb47f5d0 | 2025-11-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 67c48f86-f412-4957-8e15-aec89e07d295 | 2025-11-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 42542233-b992-4953-87ec-5095b196d61b | 2025-11-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | cd62e287-b648-459a-9414-621686c6b607 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 46d77ed8-ece2-4f51-b1a4-4a440e2dce2d | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 316e9226-e63e-466d-8143-f1edc7288fca | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Accord Healthcare Inc. | d858a6de-dda5-4bcd-a255-5723d01d896f | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | FZ989GH94E |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | FZ989GH94E |
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 68a99bb3-69ad-42e2-9d50-390f75744671 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | e505484d-b600-4d13-a4b9-278dc4a2e73a | 2025-10-20 | Warnings, Adverse reactions | 310812 WS821Z52LQ 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 860bed38-26f2-49bb-9dba-8928cec3c42c | 2025-10-20 | Warnings, Adverse reactions | ANDA071851 310818 WS821Z52LQ 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 02752dae-30b7-4726-b22b-985b330a2060 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 310812 WS821Z52LQ 0J48LPH2TH |
| Avalide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Sanofi-Aventis U.S. LLC | 0d91895e-c869-4b33-9b83-d55c1ad6317e | 2025-10-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | d09747f0-029e-4090-949b-e939948249b5 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 0a34f28c-20e6-4f34-9c4a-70fb258aa300 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 8a3e5be8-0a4b-48a0-817f-6e3c7674109d | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.